In the second part of my ASH 2012 interview, Dr. Wierda gives practical advice about CAR-T trials, and a non-chemo future with the cancer knocked down with one of the small molecules and then knocked out with the immune punch of CAR-T therapy. He believes this might be a path to a cure. See bkoffman.blogspot.com
ASH 2012: Dr. Wierda offers tips on CAR-T tria... - CLL Support
ASH 2012: Dr. Wierda offers tips on CAR-T trials and its possible future in conjunction with small molecules and the possibility of a cure.
Written by
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
1 Reply
•
All these videos offer a hopful future and all the researchers say that although it looks promising its still early days and anything can happen. No reseacher has a crystal ball. Many thanks.
Not what you're looking for?
You may also like...
Tuesday! Nov. 17th CLL Society Webinar \"The Future of CAR-T Therapy: Can CAR-T Cure CLL?”
17th CLL Society Webinar \\"The Future of CAR-T Therapy: Can CAR-T Cure CLL?” Claim your seat and...
My 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.
I posted a brief ASH 2018 interview with Dr. Siddiqi that hits the important practice changing data...
hu CAR-T 19 IL-18 TRIAL 14 DAY BMB REPORT AND DR. VISIT DAY 21
patient. A BMB is ordered at day 14 of this clinical trial, groggy from 1mg of atavan earlier that...
Dr Sharman provides an update on an NIH CAR-T trial for relapsed/refractory DBLC
Receptor engineered T Lymphocytes (CAR-T) were successfully used to cure at least one CLL patient....
CAR-T Therapy Inquiry
CAR-T Therapy Inquiry
Are you a patient or physician interested in CAR-T gene therapy? Call the...